Duration-dependent increase in striatal glutamate following prolonged fluphenazine administration in rats

European Journal of Pharmacology

Volumn 308, Issue 3, 1996, Pages 279-282

  See, Ronald E ^a   Lynch, Andrea M ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Caudate putamen; Fluphenazine; GABA ( aminobutyric acid); Glutamate; Microdialysis; Nucleus accumbens

Indexed keywords

4 AMINOBUTYRIC ACID; FLUPHENAZINE; GLUTAMIC ACID; NEUROLEPTIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; DOSE TIME EFFECT RELATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MICRODIALYSIS; MOTOR DYSFUNCTION; NONHUMAN; NUCLEUS ACCUMBENS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PUTAMEN; RAT;

EID: 0030601254     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00333-0     Document Type: Article

References (16)

1. Bourdelais, A. and P.W. Kalivas, 1991, High sensitivity HPLC assay for GABA in brain dialysis studies, J. Neurosci. Methods 39, 115.
2. Chapman, M.A. and R.E. See, 1996, Differential effects of unique profile antipsychotic drugs on extracellular amino acids in the ventral pallidum and globus pallidus of rats, J. Pharmacol. Exp. Ther. (in press).
3. Daly, D.A. and B. Moghaddam, 1993, Actions of clozapine and haloperidol on the extracellular levels of excitatory amino acids in the prefrontal cortex and striatum of conscious rats, Neurosci. Lett. 152, 61.
4. Gunne, L.M. and P.E. Andren, 1993, An animal model for coexisting tardive dyskinesia and tardive parkinsonism: a glutamate hypothesis for tardive dyskinesia, Clin. Neuropharmacol. 16, 90.
5. Kelley, A.E., C.G. Lang and A.M. Gauthier, 1988, Induction of oral stereotypy following amphetamine microinjection into a discrete subregion of the striatum, Psychopharmacology 95, 556.
6. Lohr, J.B., R. Kuczenski, H.S. Bracha, M. Moir and D.V. Jeste, 1990, Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia, Biol. Psychiatry 28, 535.
7. Moghaddam, B. and B.S. Bunney, 1993, Depolarization inactivation of dopamine neurons: terminal release characteristics, Synapse 14, 195.
8. Murai, S., H. Saito, E. Abe, Y. Masuda and T. Itoh, 1992, A rapid assay for neurotransmitter amino acids, aspartate, glutamate, glycine, taurine and γ-aminobutyric acid in the brain by high-performance liquid chromatography with electrochemical detection, J. Neural Trans. 87, 145.
9. Paxinos, G. and C. Watson, 1986, The Rat Brain in Stereotaxic Coordinates (2nd edn.) (Academic Press, San Diego).
10. See, R.E., 1991, Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance to acute challenge with raclopride, Neurosci. Lett. 129, 265.
11. See, R.E. and M.A. Chapman, 1994a, The neurochemical consequences of long-term antipsychotic drug administration on basal ganglia function in laboratory animals, Crit. Rev. Neurobiol., 8(1/2), 85.
12. See, R.E. and M.A. Chapman, 1994b, Chronic haloperidol, but not clozapine, produces altered oral movements and increased extracellular striatal glutamate in rats, Eur. J. Pharmacol. 263, 269.
13. See, R.E., M.A. Chapman and M. Klitenick, 1992, Chronic neuroleptic administration decreases extracellular GABA in the nucleus accumbens but not in the caudate-putamen of rats, Brain Res. 588, 177.
14. See, R.E. and A.M. Lynch, 1995, Chronic haloperidol potentiates stimulated glutamate release in caudate putamen, but not prefrontal cortex, Neuro Report 6, 1795.
15. Tsai, G., L.A. Passani, B.S. Slusher, R. Carter, L. Baer, J.E. Kleinman and J.T. Coyle, 1995, Abnormal excitatory neurotransmitter metabolism in schizophrenic brains, Arch. Gen. Psychiatry 52, 829.
16. Yamamoto, B.K. and M.A. Cooperman, 1994, Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations, J. Neurosci. 14(7), 4159.